The top 20 KEGG pathways of MLF targets include the PI3K- Akt signaling pathway (hsa04151), lipid and atherosclerosis (hsa05417), the AGE-RAGE signaling pathway in diabetic complications (hsa04933), insulin resistance (hsa04931), and type 2 diabetes mellitus (hsa04930). This evidence concerns the gene AKT1 and diabetes mellitus.